This special edition features upcoming presentations by MD Anderson researchers at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, including immunotherapy advances in human papillomavirus (HPV)-positive head and neck cancers, microbiome signatures linked with specialized immune-cell clusters, and promising early activity from novel immunotherapy drugs in advanced melanoma and colorectal cancer.
Tag: SITC
MD Anderson Research Highlights: SITC 2021 Special Edition
This special edition of MD Anderson’s Research Highlights features presentations at the Society for Immunotherapy of Caner 36th Annual Meeting.
Cancer Research Institute CEO and Director of Scientific Affairs Dr. Jill O’Donnell-Tormey Receives Inaugural Tara Withington Public Service Award from the Society for Immunotherapy of Cancer
Award honors individuals and organizations that foster and enhance the field of cancer immunotherapy through increasing public understanding, awareness, research efforts, and/or funding